Neurochemical ResearchPharmacology & ToxicologyPeer-reviewed journal article
JAK2/STAT3 signaling pathway mediates methylmercury toxicity in mouse astrocyte neuronal C8-D1A cell line
Aafia Ahmed, Maximus Wong, Abel Santamarı́aiD, João Batista Teixeira da RochaiD, Aaron B. BowmaniD, Michael AschneriD, Beatriz FerreriD
Abstract
Methylmercury (MeHg) is an environmental pollutant. Consumption of contaminated fish is the main exposure route in humans, leading to severe neurological disorders. Upon ingestion MeHg reaches the brain and selectively accumulates in astrocytes disrupting glutamate and calcium homeostasis and increasing oxidative stress. Despite extensive research, the molecular mechanisms underlying MeHg neurotoxicity remain incompletely understood. The induction of nuclear factor erythroid 2-related factor 2 (Nrf2) and its role activating antioxidant responses during MeHg-induced oxidative injury have garnered significant attention as a potential therapeutic target against MeHg toxicity. However, recent studies indicate that the Nrf2 signaling pathway alone may not be sufficient to mitigate MeHg-induced damage, suggesting the existence of other protective mechanisms. The signal transducer and activator of transcription 3 (STAT3) plays a crucial role in cell growth and survival. Several studies have also highlighted its involvement in regulating redox homeostasis, thereby preventing oxidative stress through mechanisms that involve modulation of nuclear genes that encode electron transport complexes (ETC) and antioxidant enzymes. These characteristics suggest that STAT3 could serve as a viable mechanism to mitigate MeHg toxicity, either in conjunction with or as an alternative to Nrf2 signaling. Our previous findings demonstrated that MeHg activates the STAT3 signaling pathway in the GT1-7 hypothalamic neuronal cell line, suggesting its potential role in promoting neuroprotection. Here, to elucidate the role of the STAT3 signaling pathway in MeHg neurotoxicity, we pharmacologically inhibited STAT3 using AG490 in the C8D1A astrocytic cell line exposed to 10 {micro}M MeHg. Our data demonstrated that pharmacological inhibition of STAT3 phosphorylation exacerbates MeHg-induced mortality, antioxidant responses, and ROS production, suggesting that STAT3 may contribute to neuroprotection against MeHg exposure in astrocytes.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
- Citations
- 2
- FWCI
- 0.75
- Field percentile
- top 36%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Epitranscriptomic Reader YTHDF2 Regulates SEK1(MAP2K4)-JNK-cJUN Inflammatory Signaling in Astrocytes during Neurotoxic Stress
Emir Malovic, Alyssa Ealy, … Anumantha G. Kanthasamy·iSciencePeer-reviewed·Jul 31, 2024
- Methotrexate carried in lipid core nanoparticles reduces microglial activation and is neuroprotective after ischemic cortical stroke
Edmundo Luís Rodrigues Pereira, Michelle N.C. Dias, … Walace Gomes‐Leal·bioRxiv·Jun 16, 2020
- Chemical inhibition of pathological reactive astrocytes promotes neural protection
Benjamin L.L. Clayton, James D. Kristell, … Paul J. Tesar·bioRxiv·Nov 3, 2021
- Thyrotropin-releasing hormone protects hippocampal neurons against glutamate toxicity via phosphatidylinositol 3-kinase/AKT pathway and new protein synthesis
Yina Dong, Deborah J. Watson·bioRxiv·Nov 11, 2025
- Nurr1 modulation mediates neuroprotective effects of statins
Sabine Willems, Julian Aurelio Marschner, … Daniel Merk·Advanced SciencePeer-reviewed·Apr 30, 2022
- Dietary zinc protects against methotrexate-induced neurotoxicity in rats via modulation of oxidative stress, inflammation and neuronal energy metabolism
Adejoke Y. Onaolapo, Olufemi B. Okunola, … Olakunle J. Onaolapo·bioRxiv·Apr 24, 2023